LONGEVITY MEDICAL INSTITUTE Trademark
Trademark Overview
On Wednesday, August 28, 2024, a trademark application was filed for LONGEVITY MEDICAL INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the LONGEVITY MEDICAL INSTITUTE trademark a serial number of 98721065. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, June 27, 2025. This trademark is owned by Longevity Medical Institute, LLC. The LONGEVITY MEDICAL INSTITUTE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Stem cell therapy services; Medical testing for diagnostic or treatment purposes; Healthcare and medical tourism services, namely, establishing and maintaining healthcare provider facilities in other countries for the provision of healthcare services; Medical clinic providing hormone therapy, including, bioidentical hormone replacement, human growth hormone therapy, and natural hormone therapy; Consulting services in the field of hormone replacement therapy; Regenerative medicine services; Medical imaging services; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial lines and wrinkles; Injectable botulinum toxin treatment services for medical purposes; Injectable botulinum toxin treatment services for cosmetic purposes; Providing laser therapy for treating medical conditions
General Information
| Serial Number | 98721065 |
| Word Mark | LONGEVITY MEDICAL INSTITUTE |
| Filing Date | Wednesday, August 28, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, June 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Stem cell therapy services; Medical testing for diagnostic or treatment purposes; Healthcare and medical tourism services, namely, establishing and maintaining healthcare provider facilities in other countries for the provision of healthcare services; Medical clinic providing hormone therapy, including, bioidentical hormone replacement, human growth hormone therapy, and natural hormone therapy; Consulting services in the field of hormone replacement therapy; Regenerative medicine services; Medical imaging services; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial lines and wrinkles; Injectable botulinum toxin treatment services for medical purposes; Injectable botulinum toxin treatment services for cosmetic purposes; Providing laser therapy for treating medical conditions |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, August 28, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, January 27, 2025 |
| First Use In Commerce Date | Monday, January 27, 2025 |
Trademark Owner History
| Party Name | Longevity Medical Institute, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Houston, TX 77027 |
Trademark Events
| Event Date | Event Description |
| Wednesday, August 28, 2024 | NEW APPLICATION ENTERED |
| Wednesday, August 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 4, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 11, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, April 11, 2025 | TEAS AMENDMENT OF USE RECEIVED |
| Friday, April 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 11, 2025 | AMENDMENT TO USE PROCESSING COMPLETE |
| Friday, April 11, 2025 | USE AMENDMENT FILED |
| Tuesday, April 15, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 15, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 15, 2025 | USE AMENDMENT ACCEPTED |
| Thursday, June 26, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 26, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 27, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
